These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10519407)
1. Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: incorporation into DNA is a necessary step. Rodriguez CO; Gandhi V Cancer Res; 1999 Oct; 59(19):4937-43. PubMed ID: 10519407 [TBL] [Abstract][Full Text] [Related]
2. A new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells. Yamauchi T; Nishi R; Kitazumi K; Nakano T; Ueda T Oncol Rep; 2010 Feb; 23(2):499-504. PubMed ID: 20043113 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells. Rodriguez CO; Legha JK; Estey E; Keating MJ; Gandhi V Clin Cancer Res; 1997 Nov; 3(11):2107-13. PubMed ID: 9815603 [TBL] [Abstract][Full Text] [Related]
4. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase. Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920 [TBL] [Abstract][Full Text] [Related]
5. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Verhoef V; Fridland A Cancer Res; 1985 Aug; 45(8):3646-50. PubMed ID: 2410098 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms for T-cell selective cytotoxicity of arabinosylguanine. Rodriguez CO; Stellrecht CM; Gandhi V Blood; 2003 Sep; 102(5):1842-8. PubMed ID: 12750168 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate. Catapano CV; Chandler KB; Fernandes DJ Cancer Res; 1991 Apr; 51(7):1829-35. PubMed ID: 1706219 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Sandoval A; Consoli U; Plunkett W Clin Cancer Res; 1996 Oct; 2(10):1731-41. PubMed ID: 9816124 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Borner MM; Myers CE; Sartor O; Sei Y; Toko T; Trepel JB; Schneider E Cancer Res; 1995 May; 55(10):2122-8. PubMed ID: 7743512 [TBL] [Abstract][Full Text] [Related]
11. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. Radvanyi LG; Shi Y; Mills GB; Miller RG Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826 [TBL] [Abstract][Full Text] [Related]
12. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070 [TBL] [Abstract][Full Text] [Related]
13. Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumors. Richardson F; Black C; Richardson K; Franks A; Wells E; Karimi S; Sennello G; Hart K; Meyer D; Emerson D; Brown E; LeRay J; Nilsson C; Tomkinson B; Bendele R Cancer Chemother Pharmacol; 2005 Mar; 55(3):213-21. PubMed ID: 15592840 [TBL] [Abstract][Full Text] [Related]
14. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate. Liliemark JO; Plunkett W Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676 [TBL] [Abstract][Full Text] [Related]
15. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial. Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483 [TBL] [Abstract][Full Text] [Related]
16. Arabinose furanosyl thymidine: uptake, phosphorylation and incorporation into DNA of mammalian cells. Dahmen N; Kowalzick L; Spadari S; Koch G In Vivo; 1990; 4(1):25-32. PubMed ID: 1966522 [TBL] [Abstract][Full Text] [Related]
17. Time sequential expression of markers of apoptosis induced by 1-beta-D-arabinofuranosylcytosine in human T-lymphoblastic leukemia CCRF-CEM cells. Badran A; Iwasaki H; Wano Y; Kishi S; Ueda T Anticancer Res; 2001; 21(3B):1987-95. PubMed ID: 11497288 [TBL] [Abstract][Full Text] [Related]
18. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295 [TBL] [Abstract][Full Text] [Related]
19. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells. de Vries JF; Falkenburg JH; Willemze R; Barge RM Haematologica; 2006 Jul; 91(7):912-9. PubMed ID: 16818278 [TBL] [Abstract][Full Text] [Related]